헤더 로고

• All Rooms
• Galaxy Theater & Discovery Hall
• Galaxy Theater
• Discovery Hall
• Universe Arena
• Supernova Stage

March 26 (Thursday)

[JS01] Joint Session 01 (Asia Session): New Era of MPN Treatment Galaxy Theater

• March 26 (Thu), 09:00-10:15
• TBD
• 09:00-09:25 Advances and Insights in Molecular Monitoring for Myeloproliferative Neoplasms Hsin-An Hou (National Taiwan University Hospital, Taiwan) 09:25-09:50 Recent Therapeutic Advances in Early MF Winnie Teo (Alexandra Hospital, Singapore) 09:50-10:15 Optimizing Treatment Strategies in Higher MF and Beyond Sung-Eun Lee (College of Medicine, The Catholic University of Korea, Korea)

[SS01] Scientific Session 01: Novel Managements Tools for Hemophilia Discovery Hall

• March 26 (Thu), 09:00-10:15
• TBD
• 09:00-09:25 Recent Advances in the Diagnosis and Management of Acquired Hemophilia A Shin Young Hyun (Yonsei University College of Medicine, Korea) 09:25-09:50 Clinical Advances and Challenges in Gene Therapy Ben Samelson-Jones (The Children's Hospital of Philadelphia, USA) 09:50-10:15 Role of Bispecific Antibody in Hemophilia Claude Négrier (University of Lyon, France)

[SS02] Scientific Session 02: ALL 2026: Shifting Standards and Emerging Innovations Universe Arena

• March 26 (Thu), 09:00-10:15
• TBD
• 09:00-09:25 Integration of MRD and Genetics as a Therapeutic Guidepost in ALL Anthony Moorman (Newcastle University, UK) 09:25-09:50 Modern Immunotherapeutics in B-ALL: BiTEs, ADCs, and Beyond Jae-Ho Yoon (College of Medicine, The Catholic University of Korea, Korea) 09:50-10:15 Optimizing Frontline Therapy in Ph+ ALL: The Role of Ponatinib and Beyond Nicholas J. Short (The University of Texas MD Anderson Cancer Center, USA)

[ES01] Education Session 01: FOCUS ON: Indolent B-cell Lymphomas Supernova Stage

• March 26 (Thu), 09:00-10:15
• TBD
• 09:00-09:25 Mantle Cell Lymphoma Jaewon Hyung (University of Ulsan College of Medicine, Korea) 09:25-09:50 Chronic Lymphocytic Leukemia Jongheon Jung (National Cancer Center, Korea) 09:50-10:15 Marginal Zone Lymphoma Sang-A Kim (Seoul National University College of Medicine, Korea)

[PL01] Plenary Lecture 01 Galaxy Theater & Discovery Hall

• March 26 (Thu), 10:30-11:15
• TBD
• 10:30-11:15 Leukemic Stem Cells in 2026: Hierarchies, Heterogeneity, and Therapeutic Resistance John E. Dick (University Health Network, Canada)

[PS01] Presidential Symposium 01 Galaxy Theater & Discovery Hall

• March 26 (Thu), 11:15-12:00
• TBD
• 11:15-12:00 Targeted Treatment of Aggressive B-cell Lymphomas Wyndham H. Wilson (National Cancer Institute, USA)

[SS03] Scientific Session 03: Geriatric Hematology Discovery Hall

• March 26 (Thu), 15:25-16:40
• TBD
• 15:25-15:50 Integrating Comprehensive Geriatric Assessment into Hematology Practice: Identifying Frailty and Optimizing Care for Older Adults Jung-Yeon Choi (Seoul National University Bundang Hospital, Korea) 15:50-16:15 Redefining Risk in Elderly AML: The GA Approach Byung Sik Cho (College of Medicine, The Catholic University of Korea, Korea) 16:15-16:40 Psycho-oncological Interventions in Geriatric Hematology: Enhancing Quality of Life Juhee Cho (Samsung Advanced Institute for Health Sciences & Technology, Korea)

[SS04] Scientific Session 04: Next-Generation Cell Therapies: In Vivo CAR Engineering, Myeloid Modulation, and Beyond Universe Arena

• March 26 (Thu), 15:25-16:40
• TBD
• 15:25-15:50 Affinity Tuning and Cytokine Modulation in CAR-T and CAR-NK Therapy Challice Bonifant (Johns Hopkins University School of Medicine, USA) 15:50-16:15 Lessons from Hemophagocytic Lymphohistiocytosis: Taming the Cytokine Storm in CAR-T Cell Therapy Michael B. Jordan (Cincinnati Children’s Hospital Medical Center, USA) 16:15-16:40 Myeloid Cells as Mediators of Cell Therapy: From Suppression to Activations Seunghee Kim-Schulze (Icahn School of Medicine at Mount Sinai, USA)

[ES02] Education Session 02: Recent Advances in Acute Leukemia Supernova Stage

• March 26 (Thu), 15:25-16:40
• TBD
• 15:25-15:50 FLT3 Positive AML Ik-Chan Song (Chungnam National University College of Medicine, Korea) 15:50-16:15 B-cell ALL with High Risk Features in Adults Dong Won Baek (Kyungpook National University School of Medicine, Korea) 16:15-16:40 Understanding and Clinical Approach to Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Hee Young Ju (Sungkyunkwan University School of Medicine, Korea)

[SS05] Scientific Session 05: MDS: Perspectives from Multiple Viewpoints Galaxy Theater

• March 26 (Thu), 16:55-18:10
• TBD
• 16:55-17:20 Insights into DDX41 Mutations: Relatively Common Genetic Aberrations in Korean MDS Patients Hongtae Kim (Ulsan National Institute of Science and Technology, Korea) 17:20-17:45 Few Drug Approvals in MDS: Lessons and Insights from a Decade of Clinical Trials Maximilian Stahl (Yale University School of Medicine, USA) 17:45-18:10 Clinical Approach to Relapsed or Refractory Lower-Risk Myelodysplastic Syndromes Valeria Santini (University of Florence, Italy)

[SS06] Scientific Session 06: Focus on Telomeres in Hematology Discovery Hall

• March 26 (Thu), 16:55-18:10
• TBD
• 16:55-17:20 Recent Advances in the Genetics of Telomere Biology Disorders Sharon A. Savage (National Institutes of Health, USA) 17:20-17:45 Role of Clonal Hematopoiesis in the Short Telomere Syndromes Kristen E. Schratz (Johns Hopkins University School of Medicine, USA) 17:45-18:10 Dyskeratosis Congenita and Related Telomere Biology Disorders Inderjeet Dokal (Queen Mary University of London, UK)

[SS07] Scientific Session 07: Advancing Immunotherapy in Multiple Myeloma: Mechanisms and Next-Generation Strategies Universe Arena

• March 26 (Thu), 16:55-18:10
• TBD
• 16:55-17:20 Next-Generation Effector Cells in Myeloma Immunotherapy Hyunsoo Cho (Seoul National University Hospital, Korea) 17:20-17:45 Natural Killer Cell-Based Immunotherapy in Multiple Myeloma Seung-Hwan Lee (University of Ottawa, Canada) 17:45-18:10 Resistant Mechanisms and Newer Immunogenic Targets in Relapsed or Refractory Multiple Myeloma Marta Chesi (Mayo Clinic, USA)

[ES03] Education Session 03: Integrated Laboratory Perspectives in Hematologic Malignancies: From Initial Workup to Transplantation Supernova Stage

• March 26 (Thu), 16:55-18:10
• TBD
• 16:55-17:20 Procedures and Interpretation of Bone Marrow Examination Seung Yeob Lee (Jeonbuk National University Medical School, Korea) 17:20-17:45 Diagnostic and Monitoring Approaches Focused on Minimal Residual Disease Miyoung Kim (University of Ulsan College of Medicine, Korea) 17:45-18:10 Blood Bank Testing before and after Hematopoietic Stem Cell Transplantation Dong Wook Jekarl (College of Medicine, The Catholic University of Korea, Korea)